Does TOCILIZUMAB Cause Dyslipidaemia? 98 Reports in FDA Database

Q: Does TOCILIZUMAB cause Dyslipidaemia?

98 reports of Dyslipidaemia have been filed with the FDA for TOCILIZUMAB, representing 0.1% of all TOCILIZUMAB adverse event reports.

Q: How dangerous is Dyslipidaemia from TOCILIZUMAB?

Of 98 reports, 3 (3.1%) resulted in death and 19 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Dyslipidaemia have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.1% of all adverse event reports for TOCILIZUMAB.

Reports of Dyslipidaemia with TOCILIZUMAB

0.1%

of all TOCILIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Dyslipidaemia From TOCILIZUMAB?

Of the 98 reports, 3 (3.1%) resulted in death, 19 (19.4%) required hospitalization, and 2 (2.0%) were considered life-threatening.

Is Dyslipidaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 98 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Dyslipidaemia?

OLANZAPINE (230) ROSUVASTATIN (206) ARIPIPRAZOLE (185) METHOTREXATE (175) QUETIAPINE (161) ATORVASTATIN (155) RISPERIDONE (154) METFORMIN (151) TACROLIMUS (149) ZIPRASIDONE (149)

Which TOCILIZUMAB Alternatives Have Lower Dyslipidaemia Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

TOCILIZUMAB Full Profile All Dyslipidaemia Reports All Drugs Causing Dyslipidaemia TOCILIZUMAB Demographics